SPARC-null mice exhibit lower intraocular pressures

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 8, 2009, Pages 3771-3777

  Haddadin, Ramez I ^a   Oh, Dong Jin ^a   Kang, Min Hyung ^a   Filippopoulos, Theodoros ^a   Gupta, Meenakashi ^a   Hart, Lois ^a   Helene Sage, E ^b   Rhee, Douglas J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEONECTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR FORMATION; AQUEOUS HUMOR OUTFLOW; ARTICLE; BIOMICROSCOPY; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORNEA THICKNESS; FEMALE; FLUOROPHOTOMETRY; HETEROZYGOTE; HISTOLOGY; INTRAOCULAR PRESSURE; IRIDOCORNEAL ANGLE; MALE; MICROSCOPY; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; VISUAL SYSTEM PARAMETERS; WILD TYPE; ACOUSTIC MICROSCOPY; ANIMAL; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; C57BL MOUSE; CORNEA; CYTOLOGY; ECHOGRAPHY; GENE DELETION; METABOLISM; MOUSE MUTANT; OCULOPLETHYSMOGRAPHY; PHYSIOLOGY;

ANIMALS; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; CIRCADIAN RHYTHM; CORNEA; FEMALE; FLUOROPHOTOMETRY; GENE DELETION; INTRAOCULAR PRESSURE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ACOUSTIC; OSTEONECTIN; TOMOGRAPHY, OPTICAL COHERENCE; TONOMETRY, OCULAR;

EID: 68349110774     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2489     Document Type: Article

References (54)

1. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma: The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504.
2. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study: prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821-829.
3. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. JAMA. 1991;266:369-374.
4. Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC. Barbados Eye Studies Group: incident open-angle glaucoma and intraocular pressure. Ophthalmology. 2007;114:1810-1815.
5. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783-801.
6. Lütjen-Drecoll E, Shimizu T, Rohrbach M, Rohen JW. Quantitative analysis of 'plaque material' between ciliary muscle tips in normaland glaucomatous Eyes. Exp Eye Res. 1986;42:457-465.
7. Bradley JM, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
8. Richter M, Krauss AHP, Woodward DF, Lütjen-Drecoll E. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci. 2003;44(10):4419-4426.
9. Weinreb RN, Kashiwagi K, F Kashiwagi, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Opthalmol Vis Sci. 1997; 38(13):2772-2780.
10. Rohen JW, Lütjen-Drecoll E, Flügel C, Meyer M, Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma. Exp Eye Res. 1993;56:683-692.
11. Aihara M, Lindsey JD, Weinreb RN. Ocular hypertension in mice with a targeted type I collagen mutation. Invest Ophthalmol Vis Sci. 2003;44(4):1581-1585.
12. Motamed K, Sage EH. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J Cell Biochem. 1998;70:543-552.
13. Yan Q, Sage EH. SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem. 1999;47:1495-1505.
14. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem. 2004;92(4):679-690.
15. Allanore Y, Wipff J, Kahan A, Boileau C. Genetic basis for systemic sclerosis. Joint Bone Spine. 2007;74(6):577-583.
16. Blazejewski S, Le Bail B, Boussarie L, et al. Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts. Am J Pathol. 1997;151(3):651-657.
17. Frizell E, Liu SL, Abraham A, et al. Expression of SPARC in normal and fibrotic livers. Hepatology. 1995; 21(3):847-854.
18. Delany AM, McMahon DJ, Powell JS, Greenberg DA, Kurland ES. Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis. Osteoporos Int. 2008; 19(7):969-978.
19. Pichler RH, Hugo C, Shankland SJ, et al. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int. 1996;50(6):1978-1989.
20. Nakken KE, Nygård S, Haalang T, et al. Multiple inflammatory-, tissue remodelling- and fibrosis genes are differentially transcribed in the livers of Abcb4 (-/-) mice harbouring chronic cholangitis. Scand J Gastroenterol. 2007;42(10):1245-1255.
21. Norose K, Clark JI, Syed NA, et al. SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci. 1998; 39(13):2674-2680.
22. Bradshaw AD, Reed MJ, Sage EH. SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem. 2002; 50:1-10.
23. Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Sage EH. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol. 2003;120:949-955.
24. Bradshaw AD, Graves DC, Motamed K, Sage EH. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci U S A. 2003;100(10):6045-6050.
25. Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest. 2000;105:915-923.
26. Bassuk JA, Birkebak T, Rothmier JD, et al. Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp Eye Res. 1999;68(3):321-331.
27. Puolakkainen P, Bradshaw AD, Kyriakides TR, et al. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. Am J Pathol. 2003; 162(2):627-635.
28. Taneda S, Pippin JW, Sage EH, et al. Amelioration of diabetic nephropathy in SPARC-null Mice. J Am Soc Nephrol. 2003;14:968-980.
29. Yan Q, Clark JI, Sage EH. Expression and characterization of SPARC in human lens and in the aqueous and vitreous humors. Exp Eye Res. 2000;71:81-90.
30. Berryhill BL, Kane B, Stramer BM, Fini ME, Hassell JR. Increased SPARC accumulation during corneal repair. Exp Eye Res. 2003; 77(1):85-92.
31. Kantorow M, Huang Q, Yang XJ, et al. Increased expression of osteonectin/SPARC mRNA and protein in age-related human cataracts and spatial expression in the normal human lens. Mol Vis. 2000; 6:24 -29.
32. Pang IH, Hellberg PE, Fleenor DL, Jacobson N, Clark AF. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:3485-3493.
33. Oh DJ, Martin JL, Williams AJ, Russell P, Birk DE, Rhee DJ. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47(9):3887-3895.
34. Rhee DJ, Fariss RN, Brekken R, Sage EH, Russell P. The matricellular protein SPARC is expressed in human trabecular meshwork. Exp Eye Res. 2003;77:601-607.
35. Gilbert RE, Cox AJ, Kelly DJ, et al. Localization of secreted protei acidic and rich in cysteine (SPARC) expression in the rat eye. Connect Tissue Res. 1999;40(4):295-303.
36. Tomarev SI, Wistow G, Raymond V, Dubois S, Malyukova I. Gene expression profile of the human trabecular meshwork: NEIBank sequence tag analysis. Invest Ophthalmol Vis Sci. 2003;44:2588-2596.
37. Vittal V, Rose A, Gregory KE, Kelly MJ, Acott TS. Changes in gene expression by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2005;46:2857-2868.
38. Smith RS, Zabaleta A, Savinova OV, John SW. The mouse anterior chamber angle and trabecular meshwork develop without cell death. BMC Dev Biol. 2001;1:3.
39. Wang WH, Millar JC, Pang IH, Wax MB, Clark AF. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005;46(12):4617-4621.
40. Saeki T, Aihara M, Ohashi M, Araie M. The Efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure: comparison with TonoPen and Microneedle Manometery. Curr Eye Res. 2008;33(3):247-252.
41. Aihara M, Lindsey JD, Weinreb RN. Reduction in intraocular pressure in mouse eyes treated with latanoprost. Invest Ophthalmol Vis Sci. 2002;43(1):146-150.
42. Savinova OV, Sugiyama F, Martin JE, et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001;2:12.
43. Aihara M, Lindsey JD, Weinreb RN. Twenty-four-hour pattern of mouse intraocular pressure. Exp Eye Res. 2003;77:681-686.
44. Danias J, Kontiola AI, Filippopoulos T, Mittag T. Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci. 2004;44(3):1138-1141.
45. Nissirios N, Ramos-Esteban J, Danias J. Ultrasound biomicroscopy of the rat eye: effects of choloinergic and anticholinergic agents. Graefes Arch Clin Exp Ophthalmol. 2005;243:469-473.
46. Nissirios N, Goldblum D, Rohrer K, Mittag T, Danias J. Noninvasive determination of intraocular pressure (IOP) in nonsedated mice of 5 different inbred strains. J Glaucoma. 2007;16(1):57-61.
47. Asai-Coakwell M, Backhouse C, Casey RJ, Gage PJ, Lehmann OJ. Reduced human and murine corneal thickness in an Axenfeld-Rieger syndrome subtype. Invest Ophthalmol Vis Sci. 2006; 47(11):4905-4909.
48. Avila MY, Mitchell CH, Stone RA, Civan MM. Noninvasive assessment of aqueous humor turnover in the mouse eye. Invest Ophthalmol Vis Sci. 2003;44:722-727.
49. Burnstein NL. Preservative alteration of corneal permeability in humans and rabbits. Invest Ophthalmol Vis Sci. 1984;25:1453-1457.
50. Schulz D, Iliev ME, Frueh BE, Goldblum D. In vivo pachymetry in normal eyes of rates, mice and rabbits with the optical low coherence reflectometer. Vision Res. 2003;43:723-728.
51. Lindsey JD, Weinreb RN. Identification of the mouse uveoscleral outflow pathway using fluorescent dextran. Invest Ophthalmol Vis Sci. 2002;43:2201-2205.
52. Richter M, Krauss AHP, Woodward DF, Lütjen-Drecoll E. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci. 2003;44:4419-4426.
53. Lindsey JD, Weinreb RN. Elevated intraocular pressure and transgenic applications in the mouse. J Glaucoma. 2005;13:318-320.
54. Flügel-Koch C, Ohlmann A, Fuchshofer R, Welge-Lüssen U, Tamm ER. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-β1 and dexamethasone in vitro. Exp Eye Res. 2004;79:649-663.